Charles Michaud Jr. - 25 Mar 2024 Form 4 Insider Report for Q32 Bio Inc. (QTTB)

Role: Former Vice President, Corporate Controller and Treasurer of Homology Medicines, Inc.
Signature: /s/ Charles Michaud, Jr.
Issuer symbol: QTTB
Transactions as of: 25 Mar 2024
Net transactions value: -$1,815
Form type: 4
Filing time: 23 Apr 2024, 17:00:03 UTC
Previous filing: 05 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	QTTB	Common Stock	Sale	$1,815	-75	-7.5%	$24.20^*	927	25 Mar 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Charles Michaud Jr. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Id	Content
F1	The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of the RSUs.
F2	On March 25, 2024, the Issuer effected a 1-for-18 reverse stock split (the "Reverse Stock Split"). The share counts herein have been adjusted to reflect the Reverse Stock Split.

Former Vice President, Corporate Controller and Treasurer of Homology Medicines, Inc.